Anna McCollister-Slipp

Chief Advocate for Participatory Research, Scripps Translational Science Institute

Anna McCollister-Slipp is Chief Advocate for Participatory Research for the Scripps Translational Science Institute (STSI). In addition, she is co-founder of Galileo Analytics, a visual data exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data.

At Scripps, Anna works with STSI researchers to develop new ways of involving patients, caregivers and physicians in the design of clinical research using digital and genomic health tools. She is founder of VitalCrowd, a new platform she is developing with STSI to help facilitate, encourage and incentivize patients, caregivers, researchers and funders to work collaboratively in designing health research that will inform and improve care for health and disease.

Anna’s passion for innovation in health data analytics, participatory research and digital health tools is rooted in her personal experiences living with type 1 diabetes. In her professional and volunteer activities, Anna seeks to build platforms for better understanding of and engagement with the needs of patients. As a health IT entrepreneur and patient advocate, Anna has been appointed to and served on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex chronic health conditions, such as diabetes. She speaks frequently about the promise of digital health, the need for innovation in medical device data and technology, promoting data standards, device interoperability and user platforms aimed at empowering patients to better manage their health.

Anna’s work as an advocate and entrepreneur has been featured in an array of publications and online media, including Forbes, Huffington Post and US News & World Report. She was named by XX In Health as a “Woman to Watch” at Health Datapalooza 2013, and as co-founder of Galileo Analytics, was one of a select group of innovators invited to participate in “The Hive” at TEDMED 2013.

Prior to her work in digital health, Anna worked in global communications and public affairs, advising clients and working for organizations involved in array off issues, ranging from economic and foreign policy to global public health and pharmaceutical product launches.